The U.S. Justice Department claims the wholesale drug distributor failed to report more than 12,000 retail pharmacy orders to the DEA since 2014.
As part of the settlement, Morris & Dickson also agreed to spend millions of dollars to hire staff and improve its oversight of controlled substances.
Morris & Dickson did not admit any wrongdoing. However, the company told CNBC, “the opioid crisis is real, and we unequivocally accept our responsibility to do everything in our control as a distributor to prevent misuse — while also protecting deserving patients’ ability to receive the doctor-prescribed medications they absolutely need.”
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer
